Cargando…
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
SIMPLE SUMMARY: Glioblastomas are the most common and aggressive brain tumors in adults, with a median survival of 15 months. Treatment is surgical removal, followed by chemotherapy and/or radiotherapy. Current chemotherapeutics do not kill all the tumor cells and some cells survive, leading to the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265128/ https://www.ncbi.nlm.nih.gov/pubmed/35804976 http://dx.doi.org/10.3390/cancers14133203 |